Page 520 - O_Desenvolvimento_do_Autismo
P. 520

MADSEN, K. M.; HVIID, A.; VESTERGAARD, M.; SCHENDEL, D.;
                WOHLFAHRT, J.; THORSEN, P.; OLSEN, J. e MELBYE, M. “A
                population-based study of measles, mumps, and rubella vaccination and

                autism”. New England Journal of Medicine 347(19), 2002, pp. 1.477-1.482.






                MAES, L.; VOLKMAN, F.; HOOKS, M. e CICCHETTI, D. “Differentiating
                pervasive developmental disorder not otherwise specified from autism and
                language disorders”. Journal of Autism Developmental Disorders 23, 1993,
                pp. 79-90.






                MAGNÚSSON, P. e SAEMUNDSEN, E. “Prevalence of autism in Iceland”.
                Journal of Autism and Developmental Disorders 31, 2001, pp. 153-163.






                MALONE, R. P.; MAISLIN, G.; CHOUDHURY, M. S.; GIFFORD, C. e
                DELANEY, M. A. “Risperidone treatment in children and adolescents with

                autism: short-and long-term safety and effectiveness”. Journal of the
                American Academy of Child and Adolescent Psychiatry 41, 2002, pp. 140-
                147.






                MANJIVIONA, J. e PRIOR, M. “Comparison of Asperger syndrome and
                high functioning autistic children on a test of motor impairment”. Journal of
                Autism and Developmental Disorders 25, 1995, pp. 23-39.






                MAURER, D. e MAURER, C. The world of the newborn. Nova York: Basic

                Books, 1988.
   515   516   517   518   519   520   521   522   523   524   525